CIK 0002070534 · Biological Products, (No Diagnostic Substances) (SIC 2836) · Nasdaq · incorporated in E9 · fiscal year ends 12/31
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-09 | S-8 | FORM S-8 | |
| 2026-10-01 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-10-01 | 4 | OWNERSHIP DOCUMENT | 2026-09-29 |
| 2026-09-24 | 6-K | FORM 6-K | 2026-09-24 |
| 2026-09-01 | 4 | OWNERSHIP DOCUMENT | 2026-08-31 |
| 2026-09-01 | 6-K | FORM 6-K | 2026-09-01 |
| 2026-08-27 | 6-K | FORM 6-K | 2026-08-27 |
| 2026-08-14 | 424B3 | 424B3 | |
| 2026-08-12 | EFFECT | EFFECT items ,, | |
| 2026-07-31 | F-1 | F-1 | |
| 2026-07-10 | 6-K | FORM 6-K | 2026-07-10 |
| 2026-06-18 | SCHEDULE 13D | SCHEDULE 13D | |
| 2026-06-18 | 3 | OWNERSHIP DOCUMENT | 2026-06-12 |
| 2026-06-18 | 20-F | ANNUAL REPORT | 2026-06-12 |
| 2026-06-17 | 3 | OWNERSHIP DOCUMENT | 2026-06-12 |
| 2026-06-16 | 3 | OWNERSHIP DOCUMENT | 2026-06-12 |
| 2026-06-16 | 3 | OWNERSHIP DOCUMENT | 2026-06-12 |
| 2026-06-16 | 3 | OWNERSHIP DOCUMENT | 2026-06-12 |
| 2026-06-16 | 3 | OWNERSHIP DOCUMENT | 2026-06-12 |
| 2026-06-16 | 3 | OWNERSHIP DOCUMENT | 2026-06-12 |
| 2026-06-16 | 3 | OWNERSHIP DOCUMENT | 2026-06-12 |
| 2026-06-15 | 3 | PRIMARY DOCUMENT | 2026-06-15 |
| 2026-06-15 | 6-K | FORM 6-K | 2026-06-15 |
| 2026-06-12 | CERT | CERT | |
| 2026-06-11 | 8-A12B | FOR REGISTRATION OF CERTAIN CLASSES |
Forms on file (last 1,000): 3 9, 425 6, 6-K 5, DRS/A 3, 4 2, 424B3 2, EFFECT 2, S-8 1. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=SLBT (0.002 USD), /gw/filings/filings?ticker=SLBT&form=8-K, /gw/filings/facts?ticker=SLBT&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange